{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:44:35Z","timestamp":1791819875343,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204821\/Z\/16\/Z"],"award-info":[{"award-number":["204821\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijid.2026.108952","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:46:04Z","timestamp":1783529164000},"page":"108952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative assessment of host transcriptomic- and bacteriological- markers for monitoring treatment response among active tuberculosis patients: a longitudinal study"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3746-398X","authenticated-orcid":false,"given":"Ritah","family":"Nakiboneka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Margaritella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonney S.","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Walbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Musisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikwese","family":"Tionge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marriott","family":"Nliwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisomo L.","family":"Msefula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-2791","authenticated-orcid":false,"given":"Wilber","family":"Sabiiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108952_bib0001","series-title":"Global tuberculosis report 2024","year":"2024"},{"key":"10.1016\/j.ijid.2026.108952_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01992-18","article-title":"Molecular bacterial load assay concurs with culture on NaOH-induced loss of mycobacterium tuberculosis viability","volume":"57","author":"Mtafya","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2026.108952_bib0003","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/thoraxjnl-2019-214238","article-title":"Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis molecular bacterial load assay","volume":"75","author":"Sabiiti","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2026.108952_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/7d9ec449-aee0-48fe-8111-0c110850c0c1","article-title":"Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers","volume":"8","author":"Bloom","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108952_bib0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2026.108952_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01441","article-title":"Detection of tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on antiretroviral therapy","volume":"10","author":"Darboe","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2026.108952_bib0007","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tube.2015.04.008","article-title":"A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases","volume":"95","author":"Laux Da Costa","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijid.2026.108952_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001538","article-title":"Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study","volume":"10","author":"Kaforou","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2026.108952_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046191","article-title":"Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy","volume":"7","author":"Bloom","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108952_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jis499","article-title":"Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response","volume":"207","author":"Cliff","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108952_bib0011","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1183\/13993003.03492-2020","article-title":"Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model","volume":"58","author":"Heyckendorf","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108952_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2017.08.004","article-title":"Host blood RNA signatures predict the outcome of tuberculosis treatment","volume":"107","author":"Thompson","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijid.2026.108952_bib0013","series-title":"National Tuberculosis Control programme manual","year":"2012"},{"key":"10.1016\/j.ijid.2026.108952_bib0014","series-title":"Module 4: treatment and care","year":"2022"},{"key":"10.1016\/j.ijid.2026.108952_bib0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00804-2021","article-title":"World Health Organization treatment outcome definitions for tuberculosis: 2021 update","volume":"58","author":"Linh","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108952_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-77164-5","article-title":"Specific human gene expression in response to infection is an effective marker for diagnosis of latent and active tuberculosis","volume":"14","author":"Nakiboneka","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.108952_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66486-z","article-title":"Suppression of host gene expression is associated with latent TB infection: a possible diagnostic biomarker","volume":"14","author":"Nakiboneka","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.108952_bib0018","unstructured":"IDT. Primer analysis tool and Tm calculator. https:\/\/eu.idtdna.com\/pages\/tools\/oligoanalyzer?returnurl=%2Fcalc%2Fanalyzer (Accessed May 4, 2026)."},{"key":"10.1016\/j.ijid.2026.108952_bib0019","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JCM.00547-11","article-title":"Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum mycobacterium tuberculosis bacillary load during treatment","volume":"49","author":"Honeyborne","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2026.108952_bib0020","series-title":"RStudio: integrated development environment for R","year":"2023"},{"key":"10.1016\/j.ijid.2026.108952_bib0021","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tube.2015.04.008","article-title":"A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases","volume":"95","author":"Laux Da Costa","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijid.2026.108952_bib0022","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1542\/peds.2011-2107LLLL","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"128","author":"Firszt","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2026.108952_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00367-1","article-title":"Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB\/RIF ultra, and culture in Uganda","volume":"5","author":"Musisi","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.108952_bib0024","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/infdis\/jiz595","article-title":"Lack of weight gain during the first 2 months of treatment and Human immunodeficiency virus independently predict unsuccessful treatment outcomes in tuberculosis","volume":"221","author":"Peetluk","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108952_bib0025","series-title":"Target product profiles for tuberculosis preventive treatment","year":"2023"},{"key":"10.1016\/j.ijid.2026.108952_bib0026","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/eji.201242847","article-title":"CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis","volume":"42","author":"Tamoutounour","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijid.2026.108952_bib0027","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V78.4.885.885","article-title":"Neutrophils express the high affinity receptor for IgG (FcyRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor","volume":"78","author":"Repp","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2026.108952_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1217141","article-title":"GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals","volume":"336","author":"Shenoy","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijid.2026.108952_bib0029","doi-asserted-by":"crossref","first-page":"26575","DOI":"10.18632\/oncotarget.5576","article-title":"Targeting Batf2 for infectious diseases and cancer","volume":"6","author":"Guler","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijid.2026.108952_bib0030","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1038\/s41598-020-65043-8","article-title":"RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response","volume":"10","author":"Penn-Nicholson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.108952_bib0031","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jis034","article-title":"New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future","volume":"205","author":"Lienhardt","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108952_bib0032","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:45:20Z","timestamp":1791816320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S1201971226005874"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108952","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative assessment of host transcriptomic- and bacteriological- markers for monitoring treatment response among active tuberculosis patients: a longitudinal study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108952"}}